DICE Therapeutics
confirmed dose dependent target engagement and biological activity | DICE Therapeutics
Company
Deck Type
Deck date
March 2023
Slide
9 of 14
Similar slides by DICE Therapeutics
See diffirences between slides (animation)
Investor Presentation
March 2023
confirmed dose dependent target engagement and biological activity | DICE Therapeutics
Results
October 2022
anti antibodies in levels have been | DICE Therapeutics
Related slides by other companies
Vigil Neuroscience
IPO
January 2022
in target engagement demonstrated vigil | Vigil Neuroscience
Melrose
Results
September 2020
has strong value potential | Melrose
Bionomics
Results
March 2023
proof of target engagement modulates receptors in healthy volunteers a | Bionomics
Other recent decks by DICE Therapeutics
See all presentations (4 decks)
Investor Presentation
March 2023
Investor Presentation
March 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io